PGXL Labs, Essential Molecular Testing Ink National Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.

The partnership, called PGXL Partners, provides the Louisville, Ky.-based laboratory a larger sales force to address growing demand for its tests. In a statement, PGXL Labs President Roland Valdes Jr., said that the company has increased sales of its tests to thousands each month from hundreds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.